Source: Program and Abstracts. Conference titles: Annual Meeting of the Endocrine Society. Unidade: FMRP
Assunto: ENDOCRINOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GERMANO, Carla et al. Plasma Renin Activity (PRA) and Atrial Natriuretic Peptide (ANP) in the control of mineralocorticoid therapy in 21-hydroxylase deficiency. 2002, Anais.. San Francisco: Endocrini Society, 2002. . Acesso em: 17 out. 2024.APA
Germano, C., Antunes-Rodrigues, J., Castro, M., Crescêncio, J. C., Gallo Júnior, L., Moreira, A. C., & Elias, L. L. K. (2002). Plasma Renin Activity (PRA) and Atrial Natriuretic Peptide (ANP) in the control of mineralocorticoid therapy in 21-hydroxylase deficiency. In Program and Abstracts. San Francisco: Endocrini Society.NLM
Germano C, Antunes-Rodrigues J, Castro M, Crescêncio JC, Gallo Júnior L, Moreira AC, Elias LLK. Plasma Renin Activity (PRA) and Atrial Natriuretic Peptide (ANP) in the control of mineralocorticoid therapy in 21-hydroxylase deficiency. Program and Abstracts. 2002 ;[citado 2024 out. 17 ]Vancouver
Germano C, Antunes-Rodrigues J, Castro M, Crescêncio JC, Gallo Júnior L, Moreira AC, Elias LLK. Plasma Renin Activity (PRA) and Atrial Natriuretic Peptide (ANP) in the control of mineralocorticoid therapy in 21-hydroxylase deficiency. Program and Abstracts. 2002 ;[citado 2024 out. 17 ]